Literature DB >> 11180755

Medication Overuse Headache.

William B. Young1.   

Abstract

Medication overuse headache is common and affects 2% of the United States population. Simple analgesics, caffeine-containing analgesics, butalbital-containing analgesics, opioids, ergotamine, and triptans may cause medication overuse headache. The recidivism rate is higher after detoxification from butalbital and opioids than after detoxification from other substances. Treatment venues have included the patient's home, an infusion center, or a hospital setting. No consensus exists to determine the setting that is most appropriate. Patients with analgesic overuse headache have a different psychologic substrate than psychiatric substance abusers. Most should not be treated in psychiatric detoxification facilities, although, psychiatric assessment and support may be beneficial.

Entities:  

Year:  2001        PMID: 11180755     DOI: 10.1007/s11940-001-0053-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  25 in total

Review 1.  Ergotamine dependency--a review.

Authors:  J R Saper
Journal:  Headache       Date:  1987-09       Impact factor: 5.887

Review 2.  Analgesic rebound headache.

Authors:  A M Rapoport
Journal:  Headache       Date:  1988-11       Impact factor: 5.887

3.  Ergotamine tartrate dependency: features and possible mechanisms.

Authors:  J R Saper; J M Jones
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

4.  Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.

Authors:  R Hering; T J Steiner
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  Droperidol treatment of status migrainosus and refractory migraine.

Authors:  S J Wang; S D Silberstein; W B Young
Journal:  Headache       Date:  1997-06       Impact factor: 5.887

6.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

7.  Classification of daily and near-daily headaches: field trial of revised IHS criteria.

Authors:  S D Silberstein; R B Lipton; M Sliwinski
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

8.  [Chronic analgesic-induced headache].

Authors:  J Dichgans; H C Diener; W D Gerber; E J Verspohl; H Kukiolka; M Kluck
Journal:  Dtsch Med Wochenschr       Date:  1984-03-09       Impact factor: 0.628

Review 9.  Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.

Authors:  S D Silberstein; W B Young
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

Review 10.  Chronic headache syndromes.

Authors:  J R Saper
Journal:  Neurol Clin       Date:  1989-05       Impact factor: 3.806

View more
  1 in total

1.  Triptan-induced latent sensitization: a possible basis for medication overuse headache.

Authors:  Milena De Felice; Michael H Ossipov; Ruizhong Wang; Josephine Lai; Juliana Chichorro; Ian Meng; David W Dodick; Todd W Vanderah; Gregory Dussor; Frank Porreca
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.